ICD-10 code E35: Disorders of endocrine glands in diseases classified elsewhere

Key Takeaways

ICD-10 code E35 is a billable ICD-10-CM diagnosis code for disorders of endocrine glands caused by an underlying disease classified elsewhere in the tabular list.

E35 is a manifestation code: the underlying etiology code must always be sequenced first, before E35, or the claim risks denial.

Common underlying diseases that trigger E35 include sarcoidosis, amyloidosis, and hemochromatosis. Tuberculosis of the endocrine glands is excluded from use with E35 and is coded with A18.7, A18.81, or A18.82 instead.

Practice management software like Pabau supports accurate code sequencing and documentation workflows, reducing endocrine manifestation coding errors.

ICD-10 code E35 covers disorders of endocrine glands in diseases classified elsewhere. It’s a billable ICD-10-CM code for secondary endocrine gland dysfunction caused by another documented disease. As a manifestation code, E35 can never stand alone on a claim: the underlying disease’s etiology code must be sequenced first.

This guide covers how to sequence E35 correctly, which underlying diseases most commonly trigger it, and what the clinical documentation needs to show to support the code pair.

ICD-10 code E35 sits within ICD-10-CM Chapter 4 (Endocrine, nutritional and metabolic diseases, E00-E89), under the subsection E20-E35 covering disorders of other endocrine glands. It is valid for FY2026 billing. Coders working in functional medicine practice management and endocrinology will encounter this code whenever an underlying systemic disease produces secondary endocrine gland involvement.

ICD-10 code E35: Official description and billable status

The CDC/NCHS ICD-10-CM web tool lists E35 with this official description: Disorders of endocrine glands in diseases classified elsewhere. It is a billable, valid, and specific ICD-10-CM code for FY2026, confirmed across multiple coding databases and consistent with the Centers for Medicare and Medicaid Services (CMS) ICD-10 code set.

Billable status means E35 can be submitted on a claim to indicate a patient diagnosis for reimbursement purposes. However, billable does not mean it can be used as a standalone primary diagnosis. The etiology-manifestation convention in ICD-10-CM requires a paired sequencing approach every time E35 appears on a claim.

The etiology-manifestation rule for ICD-10 code E35

The phrase “in diseases classified elsewhere” is the key signal in ICD-10 code E35. According to the ICD-10-CM Official Guidelines published by CMS and the National Center for Health Statistics (NCHS), any code with this wording is a manifestation code.

It describes a condition that is the result of another disease, and that other disease must be coded first.

The sequencing rule is not optional. When E35 appears on a claim, an etiology code identifying the underlying disease must precede it. Submitting E35 alone, or placing it first in the diagnosis sequence, violates ICD-10-CM coding conventions and will typically result in a payer rejection or audit flag.

This “code first” pattern isn’t unique to E35: sequela codes like G09 follow a similar convention, always secondary and never primary.

How the etiology-first rule works in practice

The ICD-10-CM Tabular List includes instructional notes at the E35 code entry that direct the coder to “code first” the underlying disease. This instruction is embedded in the tabular list and carries binding authority for any coder or billing team using ICD-10-CM for claims submission.

• Step 1: Identify the underlying systemic disease causing the endocrine gland involvement (for example, sarcoidosis).
• Step 2: Locate the appropriate ICD-10-CM code for that underlying disease (for example, D86.89 for sarcoidosis of other sites).
• Step 3: Sequence the etiology code first on the claim.
• Step 4: Add E35 as the secondary code to identify the endocrine gland manifestation.
• Step 5: Confirm both codes appear in the documentation, with the clinical notes specifying the causal relationship between the underlying disease and the endocrine involvement.

Practices that rely on metabolic health practice software with structured encounter documentation reduce the risk of missing this paired coding step, because the system prompts for complete diagnosis entry before a claim is generated.

Underlying diseases that trigger ICD-10 code E35

E35 does not describe a disease itself. It describes what happens to an endocrine gland when a systemic disease affects it. The range of underlying diseases is broad, but certain conditions appear in clinical practice far more frequently than others.

Tuberculosis of the endocrine glands does not belong on this list as a trigger for E35. The FY2026 ICD-10-CM Excludes1 note for E35 blocks it from being coded with tuberculosis of the adrenal gland (A18.7), thyroid gland (A18.81), or endocrine gland NEC (A18.82). When TB causes the endocrine involvement, code the specific A18 code instead of pairing it with E35.

Clinical documentation must establish the causal link explicitly. A note that says “adrenal insufficiency” without specifying the underlying cause does not support E35.

The documentation needs to state, for example, “adrenal gland involvement secondary to sarcoidosis,” for the E35 and etiology code pairing to hold up under audit. Providers using clinical documentation software with structured secondary-manifestation fields will recognize this as standard etiology-manifestation practice.

E35 in the context of the E20-E35 code range

Understanding where ICD-10 code E35 sits within the E20-E35 range helps coders select the right code and avoid common misassignment errors. The E20-E35 subsection covers disorders of endocrine glands that do not involve the thyroid (E00-E07) or the pancreas (E08-E13).

The key distinction is between codes in this range that describe primary endocrine disorders versus E35, which describes secondary involvement. ICD-10-CM Chapter 4 also covers nutritional sequelae such as E68, so coders should confirm which subsection matches the documented condition before defaulting to E35.

E35 vs. E34.9: choosing the right code

The most common misassignment involves ICD-10 E34.9 (Endocrine disorder, unspecified) and E35. E34.9 is appropriate when the endocrine disorder is primary or its cause is genuinely unknown. E35 is appropriate only when a documented underlying systemic disease is causing the endocrine gland dysfunction.

Using E34.9 when E35 is clinically supported is an undercoding error. Using E35 without an identified and documented underlying disease is an overcoding error.

When the underlying disease is known but the coder cannot find a specific etiology code that captures the causal relationship, referencing the AAPC Codify ICD-10-CM lookup and the ICD-10-CM Alphabetic Index together will typically resolve the sequencing question.

How E35 fits among endocrine disorders ICD-10 codes

Most endocrine disorders ICD-10 codes stand on their own. E20.9 for hypoparathyroidism, E21.0 for primary hyperparathyroidism, E22.0 for acromegaly and pituitary gigantism, and E27.1 for primary adrenocortical insufficiency each describe a primary condition you can report without a second code.

E35 is the exception in this family. It captures endocrine gland involvement that another disease caused, so it never stands alone. When the endocrine problem is primary, use the specific code above. When a systemic disease drove it, sequence that disease first and add E35 as the manifestation.

Reduce coding errors with structured documentation workflows

Pabau's claims management tools help endocrinology and multi-specialty practices document diagnosis code pairs correctly, reducing denials from manifestation code sequencing errors. See how it works for your team.

Book a demo

Documentation requirements for ICD-10 code E35

Inadequate documentation is the most common reason E35 claims fail. The clinical record must contain three elements to support both the etiology code and E35 together.

• Confirmed underlying diagnosis: The record must identify the systemic disease causing the endocrine involvement, not just note that endocrine findings are present.
• Documented causal relationship: The provider must explicitly state that the endocrine gland disorder is a result of, secondary to, or due to the identified underlying disease.
• Specific endocrine gland identified: The notes should name which gland is affected (adrenal, thyroid, parathyroid, pituitary) rather than using generic language like “endocrine abnormality.”

Practices that use structured digital intake forms and templated clinical note fields for endocrine assessments are less likely to produce records with ambiguous causation language, because the form structure prompts the provider to capture the causal narrative at the point of care.

Using automated billing workflows that flag incomplete diagnosis pairs before claim submission adds another layer of protection against E35 denials.

What “diseases classified elsewhere” means for documentation

The phrase “classified elsewhere” means the underlying disease has its own ICD-10-CM code in a different chapter or range. The endocrine gland disorder described by E35 is a secondary manifestation of that primary disease. Documentation must make this hierarchy clear: one disease caused another, and the one that caused it is coded first.

For example, in a patient with known sarcoidosis who develops adrenal gland involvement, the clinical notes must state that the adrenal findings are attributable to the sarcoidosis, not simply that both conditions are present. Co-existence without a stated causal link does not support the etiology-manifestation code pair.

This same standard applies to any code that uses the “classified elsewhere” construction. D77 follows an identical pattern for blood disorders caused by another disease, always sequenced after its etiology code.

Billing implications of using a manifestation code

Payers approach manifestation codes differently from primary diagnosis codes. Because E35 requires an etiology code to be clinically valid, payers may apply edits that check whether a paired etiology code is present. A claim with E35 listed without an appropriate leading etiology code may be rejected outright, or it may be flagged for medical necessity review.

Medicare and most commercial payers use the CMS/NCHS ICD-10-CM Official Guidelines for Coding and Reporting, along with National Correct Coding Initiative (NCCI) edits and individual payer policy, as the baseline for claims editing.

Practices that submit E35 as a primary diagnosis on outpatient claims will encounter issues regardless of payer, because the code itself carries the “in diseases classified elsewhere” instruction.

Inpatient versus outpatient coding considerations

In inpatient settings, the principal diagnosis selection follows the Uniform Hospital Discharge Data Set (UHDDS) definition: the condition established after study to be chiefly responsible for the admission. When a patient is admitted primarily for the underlying disease (for example, sarcoidosis with secondary adrenal involvement), the underlying disease is the principal diagnosis and E35 is a secondary code.

When the endocrine manifestation itself drove the admission, sequencing becomes more complex and requires querying the attending physician for clarification before submission.

In outpatient settings, the first-listed diagnosis is the condition established or treated at the visit. E35 can appear as the first-listed code only when the etiology code appears alongside it on the claim. Most practice management and billing systems that support claims management software for specialty practices will require both codes to be present before a claim passes internal validation.

Practices managing patients with complex systemic diseases often benefit from patient record management systems that maintain a persistent problem list linking primary diagnoses to their known secondary manifestations. This reduces the risk of a coder encountering E35 in isolation without context about the underlying disease already documented in the encounter record.

Related codes and when to use them instead of E35

Selecting E35 requires confidence that no more specific code exists for the endocrine condition being described. The ICD-10-CM Alphabetic Index and Tabular List should always be checked for specificity before defaulting to E35.

When tuberculosis affects the adrenal, thyroid, or other endocrine glands, use A18.7, A18.81, or A18.82 instead of E35. These codes carry an Excludes1 note against E35, meaning they can never be coded together, even when the same underlying TB infection affects multiple endocrine glands.

For any uncertain code selection between E35 and an alternative, the PGM Billing ICD-10 tool provides searchable access to official CMS code descriptions. Cross-checking the Alphabetic Index entry for the specific clinical condition will confirm whether a more specific code than E35 exists for that particular endocrine manifestation.

Practices managing documentation for complex diagnoses may also find it useful to review medical billing compliance requirements alongside code selection guidance.

Conclusion

Manifestation code errors cost practices time and revenue. ICD-10 code E35 requires an etiology code to be sequenced first, explicit causal language in the clinical documentation, and a named endocrine gland, every time it appears on a claim. Missing any one of those three elements is enough to generate a payer query or denial.

Pabau’s claims management software helps specialty practices catch paired coding errors before submission, with structured encounter documentation that prompts for both the etiology and manifestation at the point of care. To see how Pabau reduces diagnostic code errors across endocrine and complex-system specialties, book a demo with the team.

Continue your research

Need to understand how ICD-10 coding fits into your billing workflow? Practice management software covers how integrated billing and documentation tools reduce coding errors across specialties.

Managing patients with complex systemic conditions? Functional medicine software explores how all-in-one platforms support multi-diagnosis documentation and claims accuracy.

Want to reduce claim denials from incomplete diagnosis pairs? Automated billing workflows explains how pre-submission checks catch sequencing errors before they reach the payer.

Handling HIV-related diagnoses? B20 follows its own complex sequencing rules for coding HIV disease and related conditions.

Frequently asked questions